Bigfoot Biomedical today announced the U.S. Food and Drug Administration (FDA) has issued 510(k) clearance for the Android version of the Bigfoot Unity® Mobile App, a necessary component of the Bigfoot Unity® Diabetes Management System. Given that 41 percent of U.S. smartphone users choose Android devices, this clearance enables expanded access to a large group...
Out of Practice: Why Retirement Doesn’t Always Mean You Stop Seeing Patients
When Endocrine Society past-president Richard J. Santen, MD, achieved “emeritus” status at the University of Virginia in Charlottesville, he was far from being done with practicing medicine. That’s when he decided to continue seeing patients throughout southwest Virginia from the comfort of his home and with help from telehealth technology and the Federally Funded Community... One type of bacteria found in the gut may contribute to the development of type 2 diabetes, while another may protect from the disease, according to early results from an ongoing, prospective study recently published in Diabetes. Researchers led by Mark Goodarzi, MD, PhD, director of the Endocrine Genetics Laboratory at Cedars-Sinai Medical Center...
Study Reveals Obesity-Related Trigger that Can Lead to Diabetes
People with elevated levels of insulin also have defects in an enzyme important to the processing of a key fatty acid from the diet, according to research recently published in Cell Metabolism. The study may help explain how excess weight can contribute to diabetes and may provide researchers with a target to help prevent or...
Study finds people with diabetes who fast intermittently may no longer need medication After an intermittent fasting diet intervention, patients achieved complete diabetes remission, defined as an HbA1c (average blood sugar) level of less than 6.5% at least one year after stopping diabetes medication, according to a new study published in the Endocrine Society’s Journal of Clinical...
Dexcom announced recently that the FDA has cleared its next-generation Dexcom G7 Continuous Glucose Monitoring (CGM) System for people with all types of diabetes ages two years and older. Dexcom says it is working closely with its insulin pump partners to integrate Dexcom G7 into current and future automated insulin delivery systems as quickly as...
People with diabetes are benefiting from advances in medications and technologies to lower their risk of hypoglycemia, according to a Clinical Practice Guideline issued today by the Endocrine Society. The guideline, titled “Management of Individuals with Diabetes at High Risk for Hypoglycemia: An Endocrine Society Clinical Practice Guideline,” was published online and will appear in the March 2023 print...
People with Diabetes May Benefit More from a Pancreas Transplant than Other Treatments
Results of pancreas transplantation continue to improve and up to 90% of recipients with diabetes enjoy freedom from both insulin therapy and the need for close glucose monitoring following the procedure, according to a new paper published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. Pancreas transplantation is a type of surgery in which a...
